SEVELAMER CARBONATE REDUCES PHOSPHATURIA BUT HAS NO EFFECT ON SERUMC-TERMINAL FIBROBLAST GROWTH FACTOR 23 LEVELS IN STAGE 3B/4 CKD PATIENTS : THE RESULTS OF A FRENCH, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROL, RANDOMIZED CLINICAL TRIAL

被引：0

作者：

Liabeuf, S. ^{[1
,2
]}

Ryckelink, J. P. ^{[3
]}

El Esper, N. ^{[1
]}

Urena, P. ^{[4
]}

Combe, C. ^{[5
]}

Dussol, B. ^{[6
]}

Fouque, D. ^{[7
]}

Vanhille, P. ^{[8
]}

Frimat, L. ^{[9
]}

Thervet, E. ^{[10
]}

Prie, D. ^{[11
]}

Choukroun, G. ^{[1
,2
]}

机构：

[1] CHU Amiens, Dept Nephrol, Amiens, France

[2] UPJV, INSERM, U1088, Amiens, France

[3] CHU Caen, Dept Nephrol, F-14000 Caen, France

[4] Clin Landy, Dept Nephrol, St Ouen, France

[5] CHU Bordeaux, Dept Nephrol, Bordeaux, France

[6] CHU Marseille, Dept Nephrol, Marseille, France

[7] Hop Edouard Herriot, Dept Nephrol, Lyon, France

[8] CH Valenciennes, Dept Nephrol, Valenciennes, France

[9] CHU Nancy, Dept Nephrol, Nancy, France

[10] CHU Paris HEGP, Dept Nephrol, Paris, France

[11] CHU Paris Necker, Dept Nephrol, Paris, France

来源：

关键词：

D O I：

10.1093/ndt/gfv177.8

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

FP409

引用

页数：1